Medicos ante Junta de Licenciamiento y Disciplina Medica de PR,
In a placebo-controlled trial involving immunosuppressed organ-transplant recipients, oral nicotinamide (500 mg twice daily…
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients
Overview of attention for article published in New England Journal of Medicine, March 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
Good Attention Score compared to outputs of the same age and source (67th percentile)
Mentioned by
- news
- 33 news outlets
- blogs
- 2 blogs
- 68 X users
- 2 Facebook pages
- video
- 2 YouTube creators
- guideline
- 2 clinical guideline sources
- bluesky
- 1 Bluesky user
- podcasts
- 1 podcast
Readers on
- mendeley
- 108 Mendeley